Drugs / autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00937183 | Sep 2003 → Jun 2017 | plasma cell neoplasm | Jan Walewski | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00937183 ↗ |
| Modality | Vaccine | “dendritic cell vaccine made with a patient's cancer cells” NCT00937183 ↗ |
| Route | Other | “intranodal (under ultrasound guidance) or subcutaneous vaccinations” NCT00937183 ↗ |
| Route | Subcutaneous | “intranodal (under ultrasound guidance) or subcutaneous vaccinations” NCT00937183 ↗ |